
28 February 2022
Love Hemp Group PLC
("Love Hemp" or the "Company")
Total Voting Rights
For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, Love Hemp announces that the Company has 1,198,804,631 ordinary shares of 1p each in issue, each share carrying the right to one vote.
The figure of 1,198,804,631 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
-ENDS-
For further information please visit: www.lovehempgroup.com or contact:
Love Hemp Group Andrew Male
| +44 (0) 7926 397 675 andrew.male@lovehempgroup.com
|
Financial Advisor Rupert Fane H&P Advisory Limited
| +44 (0) 20 7907 8500 rf@hannam.partners
|
AQSE Corporate Adviser Mark Anwyl Peterhouse Capital Limited
| +44 (0) 20 7469 0930 ma@peterhousecap.com
|
Financial PR Tim Blythe/Alice McLaren/Madeleine Gordon-Foxwell Blytheweigh
| +44 (0) 207 138 3204 lovehemp@blytheweigh.com |
About Love Hemp Group
Love Hemp Group is a brand-led consumer goods company focused on health and wellness solutions for consumer use cases including sleep, pain, anxiety, stress and recovery. The Company is a pioneer in the UK-based premium high-quality CBD market, with over 40 products including oils, edibles, sprays, cosmetics and topicals. The Company's range of products are sold online across 70 websites and in over 2,000 stores including some of the biggest retailers in the UK, such as Holland & Barrett, Boots and Ocado. Listed on the Aquis Stock Exchange (AQSE: LIFE) the Company recently changed its name to Love Hemp Group plc, from World High Life, to better reflect its focus on supporting the "best in class" CBD brand as it embarks on a wider expansion of its core business and offering.
Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by the Company to constitute inside information. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.